104 related articles for article (PubMed ID: 36073848)
1. Current (but not ex) cigarette smoking is associated with worse cognitive performances in schizophrenia: results from the FACE-SZ cohort.
Mallet J; Godin O; Dansou Y; Mazer N; Scognamiglio C; Berna F; Boyer L; Capdevielle D; Chéreau I; D'Amato T; Dubreucq J; Fond G; Leigner S; Llorca PM; Misdrahi D; Passerieux C; Rey R; Pignon B; Urbach M; Schorr B; Schürhoff F; Yann LS; Dubertret C;
Psychol Med; 2023 Aug; 53(11):5279-5290. PubMed ID: 36073848
[TBL] [Abstract][Full Text] [Related]
2. Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort.
Mallet J; Le Strat Y; Schürhoff F; Mazer N; Portalier C; Andrianarisoa M; Aouizerate B; Berna F; Brunel L; Capdevielle D; Chereau I; D'Amato T; Denizot H; Dubreucq J; Faget C; Gabayet F; Lançon C; Llorca PM; Misdrahi D; Rey R; Roux P; Schandrin A; Urbach M; Vidailhet P; Fond G; Dubertret C;
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):332-339. PubMed ID: 28663115
[TBL] [Abstract][Full Text] [Related]
3. Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort.
Fond G; Berna F; Andrianarisoa M; Godin O; Leboyer M; Brunel L; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Denizot H; Dubertret C; Dubreucq J; Faget C; Gabayet F; Llorca PM; Mallet J; Misdrahi D; Passerieux C; Richieri R; Rey R; Schandrin A; Urbach M; Vidailhet P; Boyer L; Schürhoff F;
Eur Arch Psychiatry Clin Neurosci; 2017 Aug; 267(5):465-472. PubMed ID: 28238173
[TBL] [Abstract][Full Text] [Related]
4. Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohort.
Mallet J; Le Strat Y; Schürhoff F; Mazer N; Portalier C; Andrianarisoa M; Aouizerate B; Berna F; Brunel L; Capdevielle D; Chereau I; D'Amato T; Dubreucq J; Faget C; Gabayet F; Honciuc RM; Lançon C; Llorca PM; Misdrahi D; Rey R; Roux P; Schandrin A; Urbach M; Vidailhet P; Fond G; Dubertret C;
Eur Arch Psychiatry Clin Neurosci; 2019 Jun; 269(4):449-457. PubMed ID: 29396753
[TBL] [Abstract][Full Text] [Related]
5. [The 10-year findings from the FondaMental Academic Center of Expertise for Schizophrenia (FACE-SZ): Review and recommendations for clinical practice].
Schürhoff F; Fond G; Berna F; Bulzacka E; Godin O; Boyer L; Misdrahi D; Andrianarisoa M; Brunel L; Coulon N; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Gabayet F; Mallet J; Rey R; Lancon C; Passerieux C; Schandrin A; Urbach M; Vidailhet P; Leboyer M; Llorca PM;
Encephale; 2019 Feb; 45(1):9-14. PubMed ID: 30327207
[TBL] [Abstract][Full Text] [Related]
6. Effects of tobacco smoking on neuropsychological function in schizophrenia in comparison to other psychiatric disorders and non-psychiatric controls.
Morisano D; Wing VC; Sacco KA; Arenovich T; George TP
Am J Addict; 2013 Jan; 22(1):46-53. PubMed ID: 23398226
[TBL] [Abstract][Full Text] [Related]
7. Smoking status and its relationship to demographic and clinical characteristics in first episode psychosis.
Grossman M; Bowie CR; Lepage M; Malla AK; Joober R; Iyer SN
J Psychiatr Res; 2017 Feb; 85():83-90. PubMed ID: 27863280
[TBL] [Abstract][Full Text] [Related]
8. Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set.
Fond G; Berna F; Boyer L; Godin O; Brunel L; Andrianarisoa M; Aouizerate B; Capdevielle D; Chereau I; Danion JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Gloahec T; Llorca PM; Mallet J; Misdrahi D; Rey R; Richieri R; Passerieux C; Portalier C; Roux P; Vehier A; Yazbek H; Schürhoff F; Bulzacka E;
Eur Arch Psychiatry Clin Neurosci; 2018 Feb; 268(1):17-26. PubMed ID: 28349247
[TBL] [Abstract][Full Text] [Related]
9. Association of Electronic Nicotine Delivery System Use With Cigarette Smoking Relapse Among Former Smokers in the United States.
Everard CD; Silveira ML; Kimmel HL; Marshall D; Blanco C; Compton WM
JAMA Netw Open; 2020 Jun; 3(6):e204813. PubMed ID: 32501492
[TBL] [Abstract][Full Text] [Related]
10. Tobacco smoking in marijuana-dependent outpatients.
Moore BA; Budney AJ
J Subst Abuse; 2001; 13(4):583-96. PubMed ID: 11775084
[TBL] [Abstract][Full Text] [Related]
11. Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study.
McClure EA; Baker NL; Sonne SC; Ghitza UE; Tomko RL; Montgomery L; Babalonis S; Terry GE; Gray KM
Drug Alcohol Depend; 2018 Nov; 192():59-66. PubMed ID: 30218864
[TBL] [Abstract][Full Text] [Related]
12. Mismatch negativity in tobacco-naïve cannabis users and its alteration with acute nicotine administration.
Impey D; El-Marj N; Parks A; Choueiry J; Fisher D; Knott VJ
Pharmacol Biochem Behav; 2015 Sep; 136():73-81. PubMed ID: 26188167
[TBL] [Abstract][Full Text] [Related]
13. Correlates of lifetime blunt/spliff use among cigarette smokers in substance use disorders treatment.
Campbell BK; Le T; Kapiteni K; Gubner NR; Guydish J
J Subst Abuse Treat; 2020 Sep; 116():108064. PubMed ID: 32741500
[TBL] [Abstract][Full Text] [Related]
14. Tobacco and Nicotine Use Among US Adult "Never Smokers" in Wave 4 (2016-2018) of the Population Assessment of Tobacco and Health Study.
Klemperer EM; Hughes JR; Callas PW; West JC; Villanti AC
Nicotine Tob Res; 2021 Jun; 23(7):1199-1207. PubMed ID: 33433608
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of depressive symptoms and cannabis use among adult cigarette smokers in Canada: cross-sectional findings from the 2020 International Tobacco Control Policy Evaluation Project Canada Smoking and Vaping Survey.
Gravely S; Driezen P; McClure EA; Smith DM; Fong GT
CMAJ Open; 2023; 11(3):E516-E526. PubMed ID: 37311596
[TBL] [Abstract][Full Text] [Related]
16. Tobacco smoking and its association with cognition in first episode psychosis patients.
Hickling LM; Perez-Iglesias R; Ortiz-García de la Foz V; Balanzá-Martínez V; McGuire P; Crespo-Facorro B; Ayesa-Arriola R
Schizophr Res; 2018 Feb; 192():269-273. PubMed ID: 28412088
[TBL] [Abstract][Full Text] [Related]
17. Trends in cannabis use disorder by cigarette smoking status in the United States, 2002-2016.
Weinberger AH; Pacek LR; Wall MM; Zvolensky MJ; Copeland J; Galea S; Nahvi S; Moeller SJ; Hasin DS; Goodwin RD
Drug Alcohol Depend; 2018 Oct; 191():45-51. PubMed ID: 30077055
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of Adult Cigarette Smokers Who "Relight" and the Effects of Exposure to Tobacco Smoke Constituents.
Allen SI; Wasserman E; Veldheer S; Yingst J; Hrabovsky S; Liao J; Krebs NM; Horn K; Reinhart L; Modesto J; Putt K; Evins AE; Muscat JE; Richie JP; Foulds J
Nicotine Tob Res; 2019 Aug; 21(9):1206-1212. PubMed ID: 29982710
[TBL] [Abstract][Full Text] [Related]
19. Cannabis Use Is Associated With Increased Risk of Cigarette Smoking Initiation, Persistence, and Relapse Among Adults in the United States.
Weinberger AH; Delnevo CD; Wyka K; Gbedemah M; Lee J; Copeland J; Goodwin RD
Nicotine Tob Res; 2020 Jul; 22(8):1404-1408. PubMed ID: 31112595
[TBL] [Abstract][Full Text] [Related]
20. Cannabis use disorders in schizophrenia: effects on cognition and symptoms.
DeRosse P; Kaplan A; Burdick KE; Lencz T; Malhotra AK
Schizophr Res; 2010 Jul; 120(1-3):95-100. PubMed ID: 20483565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
